{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:57:40Z","timestamp":1790888260051,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2021,12]]},"abstract":"Abstract<\/jats:title>\n Background<\/jats:title>\n More than 75% of patients presenting to the Emergency Department are suffering symptoms of pain. Despite this, 67% will not receive any analgesia. Methoxyflurane is a fluorinated hydrocarbon gas which has analgesic properties when inhaled. Penthrox is a methoxyflurane autoinhaler recently licenced in Europe. Its ease of administration, safety, and fast onset of action make it of particular relevance to emergency medicine. Additionally, outside the hospital, it has the advantage of increased temperature stability and portability over current standard care. New evidence of its efficacy is emerging; however, currently, its use in Europe is not widespread. The objective of this study will be to systematically evaluate the evidence on inhaled methoxyflurane to determine if it is a superior analgesia in the acute trauma setting.<\/jats:p>\n <\/jats:sec>\n Methods<\/jats:title>\n We designed and registered a study protocol for a systematic review and meta-analysis on randomised controlled trials, comparing inhaled methoxyflurane and either placebo or standard care. A comprehensive search will be conducted from database inception onwards in MEDLINE, Embase, and the Cochrane CENTRAL database, concurrent with a search of the grey literature for other relevant studies, including clinical trial databases. Only randomised controlled trials will be included. No limitations will be imposed on publication status or language of publication. The primary outcome will be mean difference in patient-reported pain at time points within the first 30\u2009min of administration. Secondary outcomes will be mean difference in time to clinically significant pain relief and relative risk of adverse effects. Two reviewers will independently screen all returned studies and collect data. Disagreements will be resolved through discussion or referral to a third reviewer. Individual study methodological quality will be appraised using an appropriate tool. If feasible, we will conduct a random effects meta-analysis; if this is not possible, we will construct a narrative synthesis.<\/jats:p>\n <\/jats:sec>\n Discussion<\/jats:title>\n This systematic review will summarise the best available evidence and definitively establish if inhaled methoxyflurane is a superior analgesia to standard care in the acute trauma setting. This knowledge will directly impact emergency care in the UK and worldwide and may require amendments to European pain relief guidelines.<\/jats:p>\n <\/jats:sec>\n Systematic review registration<\/jats:title>\n PROSPERO CRD42020189119<\/jats:ext-link>.<\/jats:p>\n <\/jats:sec>","DOI":"10.1186\/s13643-021-01600-0","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T17:03:13Z","timestamp":1612371793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Inhaled methoxyflurane (Penthrox) for analgesia in trauma: a systematic review protocol"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9104-5954","authenticated-orcid":false,"given":"Michael M.","family":"Eager","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0220-3218","authenticated-orcid":false,"given":"Grant S.","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Tonks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3774-3276","authenticated-orcid":false,"given":"Anoopama","family":"Ramjeeawon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,3]]},"reference":[{"key":"1600_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2147\/OAEM.S181222","volume":"10","author":"KM Porter","year":"2018","unstructured":"Porter KM, Dayan AD, Dickerson S, Middleton PM. The role of inhaled methoxyflurane in acute pain management. Open Access Emerg Med. 2018;10:149\u201364. https:\/\/doi.org\/10.2147\/OAEM.S181222.","journal-title":"Open Access Emerg Med"},{"key":"1600_CR2","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1097\/00000542-200610000-00031","volume":"105","author":"SN Raja","year":"2006","unstructured":"Raja SN, Mazze RI. Methoxyflurane revisited: tale of an anesthetic from cradle to grave. Anethesiology. 2006;105:843\u20136.","journal-title":"Anethesiology"},{"issue":"1","key":"1600_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1177\/0960327115578743","volume":"35","author":"AD Dayan","year":"2016","unstructured":"Dayan AD. Analgesic use of inhaled methoxyflurane. Hum Exp Toxicol. 2016;35(1):91\u2013100. https:\/\/doi.org\/10.1177\/0960327115578743.","journal-title":"Hum Exp Toxicol"},{"key":"1600_CR4","unstructured":"Schug SA, Palmer GM, Scott DA, Halliwell R, Trinca J, eds. Acute pain management: scientific evidence. Fourth Edi. Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine; 2015. www.tga.gov.au"},{"key":"1600_CR5","unstructured":"Introducing Penthrox\u00ae | Penthrox Europe \u2013 Methoxyflourane. Accessed June 1, 2020. https:\/\/www.penthrox.eu\/intro\/"},{"key":"1600_CR6","doi-asserted-by":"publisher","unstructured":"Coffey F, Wright J, Hartshorn S. STOP!: a randomised, double-blind, placebo-controlled study of the efficacy and safety of methoxyflurane for the treatment of acute pain. Emerg Med J. Published online 2014. doi:https:\/\/doi.org\/10.1136\/emermed-2014-203690","DOI":"10.1136\/emermed-2014-203690"},{"issue":"3","key":"1600_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.annemergmed.2019.07.028","volume":"75","author":"AM Borobia","year":"2020","unstructured":"Borobia AM, Collado SG, Cardona CC, et al. Inhaled methoxyflurane provides greater analgesia and faster onset of action versus standard analgesia in patients with trauma pain: InMEDIATE: a randomized controlled trial in emergency departments. Ann Emerg Med. 2020;75(3):315\u201328. https:\/\/doi.org\/10.1016\/j.annemergmed.2019.07.028.","journal-title":"Ann Emerg Med"},{"issue":"11","key":"1600_CR8","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1007\/s12325-019-01055-9","volume":"36","author":"S Mercadante","year":"2019","unstructured":"Mercadante S, Voza A, Serra S, et al. Analgesic efficacy, practicality and safety of inhaled methoxyflurane versus standard analgesic treatment for acute trauma pain in the emergency setting: a randomised, open-label, active-controlled, multicentre trial in Italy (MEDITA). Adv Ther. 2019;36(11):3030\u201346. https:\/\/doi.org\/10.1007\/s12325-019-01055-9.","journal-title":"Adv Ther"},{"key":"1600_CR9","doi-asserted-by":"publisher","unstructured":"Ricard-Hibon A, Lecoules N, Savary D, et al. Inhaled methoxyflurane for the management of trauma related pain in patients admitted to hospital emergency departments (PenASAP study). Eur J Emerg Med Published online April 2020:1. doi:https:\/\/doi.org\/10.1097\/mej.0000000000000686","DOI":"10.1097\/mej.0000000000000686"},{"issue":"2","key":"1600_CR10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.12968\/jpar.2019.11.2.54","volume":"11","author":"M Forrest","year":"2019","unstructured":"Forrest M, Porter K, van der Velde J. Methoxyflurane (Penthrox\u00ae)\u2014a case series of use in the prehospital setting. J Paramedic Practice. 2019;11(2):54\u201360. https:\/\/doi.org\/10.12968\/jpar.2019.11.2.54.","journal-title":"J Paramedic Practice"},{"issue":"2","key":"1600_CR11","doi-asserted-by":"publisher","first-page":"e034647","DOI":"10.1136\/bmjopen-2019-034647","volume":"10","author":"J Frangos","year":"2020","unstructured":"Frangos J, Belbachir A, Dautheville S, et al. Non-interventional study evaluating exposure to inhaled, low-dose methoxyflurane experienced by hospital emergency department personnel in France. BMJ Open. 2020;10(2):e034647. https:\/\/doi.org\/10.1136\/bmjopen-2019-034647.","journal-title":"BMJ Open."},{"issue":"1","key":"1600_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tjem.2018.11.003","volume":"19","author":"DH Cisewski","year":"2019","unstructured":"Cisewski DH, Motov SM. Essential pharmacologic options for acute pain management in the emergency setting. Turk J Emerg Med. 2019;19(1):1\u201311. https:\/\/doi.org\/10.1016\/j.tjem.2018.11.003.","journal-title":"Turk J Emerg Med"},{"issue":"1","key":"1600_CR13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13049-015-0166-3","volume":"23","author":"J Dale","year":"2015","unstructured":"Dale J, Bj\u00f8rnsen LP. Assessment of pain in a Norwegian Emergency Department. Scand J Trauma, Resusc Emerg Med. 2015;23(1):86. https:\/\/doi.org\/10.1186\/s13049-015-0166-3.","journal-title":"Scand J Trauma, Resusc Emerg Med"},{"key":"1600_CR14","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.2147\/JPR.S137992","volume":"10","author":"P Mura","year":"2017","unstructured":"Mura P, Serra E, Marinangeli F, et al. Prospective study on prevalence, intensity, type, and therapy of acute pain in a second-level urban emergency department. J Pain Res. 2017;10:2781\u20138. https:\/\/doi.org\/10.2147\/JPR.S137992.","journal-title":"J Pain Res"},{"key":"1600_CR15","doi-asserted-by":"publisher","unstructured":"Cohen HML, Wolstenholme R. Penthrox: a breath of PHEC air for the military? J R Army Med Corps Month. 2019;0(0). https:\/\/doi.org\/10.1136\/jramc-2018-001122.","DOI":"10.1136\/jramc-2018-001122"},{"issue":"6","key":"1600_CR16","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s12325-019-00936-3","volume":"36","author":"E Montassier","year":"2019","unstructured":"Montassier E, Freund Y. A rigorous evaluation of methoxyflurane is needed: comment on \u201cMethoxyflurane versus standard of care for acute trauma-related pain in the emergency setting: protocol for a randomised, controlled study in Italy (MEDITA)\u201d. Adv Ther. 2019;36(6):1241. https:\/\/doi.org\/10.1007\/s12325-019-00936-3.","journal-title":"Adv Ther"},{"key":"1600_CR17","doi-asserted-by":"publisher","unstructured":"J v M, Mrcsed JM. Is methoxyflurane a suitable battlefield analgesic? JR Army Med Corps. 153(2):111\u20133. https:\/\/doi.org\/10.1136\/jramc-153-02-08.","DOI":"10.1136\/jramc-153-02-08"},{"key":"1600_CR18","doi-asserted-by":"crossref","unstructured":"Griffiths E. Efficacy and safety of methoxyflurane: managing trauma associated pain in UK SAR helicopter paramedic practice. J Paramedic Pract. 2017;2;9(3):108-20.","DOI":"10.12968\/jpar.2017.9.3.108"},{"issue":"4","key":"1600_CR19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.annemergmed.2005.03.010","volume":"46","author":"PE Bijur","year":"2005","unstructured":"Bijur PE, Kenny MK, Gallagher EJ. Intravenous morphine at 0.1\u2009mg\/kg is not effective for controlling severe acute pain in the majority of patients. Ann Emerg Med. 2005;46(4):362\u20137. https:\/\/doi.org\/10.1016\/j.annemergmed.2005.03.010.","journal-title":"Ann Emerg Med"},{"key":"1600_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/JPR.S150600","volume":"11","author":"KM Porter","year":"2018","unstructured":"Porter KM, Siddiqui MK, Sharma I, Dickerson S, Eberhardt A. Management of trauma pain in the emergency setting: low-dose methoxyflurane or nitrous oxide? A systematic review and indirect treatment comparison. J Pain Res. 2018;11:11\u201321. https:\/\/doi.org\/10.2147\/JPR.S150600.","journal-title":"J Pain Res"},{"key":"1600_CR21","doi-asserted-by":"crossref","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1-9.","DOI":"10.1186\/2046-4053-4-1"},{"key":"1600_CR22","unstructured":"Higgins JPT, Thomas J, Chandler J, et al. Cochrane handbook for systematic reviews of interventions . https:\/\/training.cochrane.org\/handbook"},{"issue":"7716","key":"1600_CR23","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (Online). 2009;339(7716):332\u20136. https:\/\/doi.org\/10.1136\/bmj.b2535.","journal-title":"BMJ (Online)."},{"key":"1600_CR24","doi-asserted-by":"publisher","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1). https:\/\/doi.org\/10.1186\/s13643-016-0384-4.","DOI":"10.1186\/s13643-016-0384-4"},{"key":"1600_CR25","unstructured":"Methoxyflurane | Drug | BNF content published by NICE. Accessed June 17, 2020. https:\/\/bnf.nice.org.uk\/drug\/methoxyflurane.html"},{"key":"1600_CR26","doi-asserted-by":"publisher","unstructured":"Young T, Hopewell S. Methods for obtaining unpublished data. Cochrane Database Syst Rev. 2011;11. https:\/\/doi.org\/10.1002\/14651858.mr000027.pub2.","DOI":"10.1002\/14651858.mr000027.pub2"},{"issue":"2","key":"1600_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1161\/CIRCOUTCOMES.114.001381","volume":"8","author":"B Abell","year":"2015","unstructured":"Abell B, Glasziou P, Hoffmann T. Reporting and replicating trials of exercise-based cardiac rehabilitation: do we know what the researchers actually did? Circ Cardiovasc Qual Outcomes. 2015;8(2):187\u201394. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.114.001381.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"1600_CR28","doi-asserted-by":"publisher","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. The BMJ. 2019;366. https:\/\/doi.org\/10.1136\/bmj.l4898.","DOI":"10.1136\/bmj.l4898"},{"key":"1600_CR29","unstructured":"Review Manager Web (RevMan Web). Published online 2019. revman.cochrane.org"},{"issue":"7650","key":"1600_CR30","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.ad","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, et al. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u20136. https:\/\/doi.org\/10.1136\/bmj.39489.470347.ad.","journal-title":"BMJ."},{"key":"1600_CR31","doi-asserted-by":"publisher","unstructured":"Campbell M, McKenzie JE, Sowden A, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. The BMJ. 2020;368. https:\/\/doi.org\/10.1136\/bmj.l6890.","DOI":"10.1136\/bmj.l6890"},{"key":"1600_CR32","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334.","journal-title":"BMJ."},{"issue":"1","key":"1600_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12916-016-0775-3","volume":"15","author":"MF Olsen","year":"2017","unstructured":"Olsen MF, Bjerre E, Hansen MD, et al. Pain relief that matters to patients: systematic review of empirical studies assessing the minimum clinically important difference in acute pain. BMC Medicine. 2017;15(1):35. https:\/\/doi.org\/10.1186\/s12916-016-0775-3.","journal-title":"BMC Medicine."},{"key":"1600_CR34","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.annemergmed.2019.12.007","volume":"75","author":"E Montassier","year":"2020","unstructured":"Montassier E, Freund Y. Guidelines for letters to the editor methoxyflurane may provide faster relief than suboptimal treatment, but not better. Ann Emerg Med. 2020;75:550\u20131. https:\/\/doi.org\/10.1016\/j.annemergmed.2019.12.007.","journal-title":"Ann Emerg Med"},{"issue":"1","key":"1600_CR35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1742-6723.2009.01153.x","volume":"21","author":"J Grindlay","year":"2009","unstructured":"Grindlay J, Babl FE. Review article: efficacy and safety of methoxyflurane analgesia in the emergency department and prehospital setting. Emerg Med Australas. 2009;21(1):4\u201311. https:\/\/doi.org\/10.1111\/j.1742-6723.2009.01153.x.","journal-title":"Emerg Med Australas"},{"key":"1600_CR36","doi-asserted-by":"publisher","first-page":"MR000033","DOI":"10.1002\/14651858.MR000033.pub3","volume":"2","author":"A Lundh","year":"2017","unstructured":"Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L. Industry sponsorship and research outcome. Cochrane Database Syst Rev. 2017;2:MR000033. https:\/\/doi.org\/10.1002\/14651858.MR000033.pub3.","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-021-01600-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13643-021-01600-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-021-01600-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T17:08:17Z","timestamp":1612372097000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-021-01600-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,3]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1600"],"URL":"https:\/\/doi.org\/10.1186\/s13643-021-01600-0","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,3]]},"assertion":[{"value":"2 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}